Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by Springer, 2013
ISBN 10: 1461462959ISBN 13: 9781461462958
Seller: booksXpress, Bayonne, NJ, U.S.A.
Book
Hardcover. Condition: new.
Published by Springer, 2013
ISBN 10: 1461462959ISBN 13: 9781461462958
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer, 2016
ISBN 10: 1489979468ISBN 13: 9781489979469
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer, 2013
ISBN 10: 1461462959ISBN 13: 9781461462958
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by Springer, 2016
ISBN 10: 1489979468ISBN 13: 9781489979469
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by Springer, 2016
ISBN 10: 1489979468ISBN 13: 9781489979469
Seller: booksXpress, Bayonne, NJ, U.S.A.
Book
Soft Cover. Condition: new.
Published by Springer US Apr 2013, 2013
ISBN 10: 1461462959ISBN 13: 9781461462958
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Aerodynamic particle size characteristics of orally inhaled products (OIPs) are critical to their performance. Testing based on cascade impaction has been the primary tool used to characterize this critical quality attribute and is a regulatory expectation for Quality Control purposes. In recent years, there have been substantial efforts directed at improving aerodynamic particle size determinations.Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products brings together for the first time a review of best practices for performing cascade impactor testing with a thorough discussion of the newly introduced concepts of abbreviated impactor measurements (AIM) and efficient data analysis (EDA). Topics covered include: Review of pharmacopeial methods (US and European) for aerodynamic particle size distributions (APSD) assessment of OIPs Physical processes that underlie aerosol formation from OIPs and the mechanisms that effect the APSD Good cascade impactor practice (GCIP) related to either full resolution or abbreviated impactor measurements. Introduction of the AIM and EDA concepts Selection of the type of testing through the development lifecycle of an OIP Theoretical basis for EDA Performance evaluation of EDA as a quality control element Case studies related to the application of EDA Experimental studies validating the AIM concept conducted by European Pharmaceutical Aerosol Group (EPAG) and the Cascade Impaction Working Group of the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS). Regulatory and compendial pathways to adoption of AIM and EDA Exploration and extension of AIM as a potential approach to measures more predictive of particle deposition in the human respiratory tract. This comprehensive volume was written by a group of prominent international experts in aerosol testing led by members of the Cascade Impaction Working Group of IPAC-RS. IPAC-RS is an international association of pharmaceutical companies committed to advancing consensus-based, scientifically driven standards and regulations for orally inhaled and nasal drug products. 456 pp. Englisch.
Published by Springer US Aug 2016, 2016
ISBN 10: 1489979468ISBN 13: 9781489979469
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The purpose of this publication is to introduce a new, simpler and more effective way in which to interpret pharmaceutical aerosol particle size data from orally inhaled products (OIPs). Currently, the compendial and regulatory requirements dictate the need for measurements by full resolution multi-stage cascade impactor (CI), a process that is demanding for the operator, time consuming, prone to experimental error, and challenging for method transfers from one laboratory to another. Furthermore, we shall show that the current practice of reducing information from mass-weighted aerodynamic particle size distribution (APSD) measurements through the use of CI stage groupings is not the most effective decision-making tool for OIP quality control (QC) in comparison with newly introduced, mutually-independent efficient data analysis (EDA) metrics that can be derived either from full resolution or abbreviated impactor measurements (AIM). 456 pp. Englisch.
Published by Springer US, 2013
ISBN 10: 1461462959ISBN 13: 9781461462958
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Introduces a new, simpler and more effective way in which to interpret pharmaceutical aerosol particle size data from orally inhaled products (OIPs) Outlines a comprehensive product lifecycle management strategy in terms of in vitro characterizati.
Published by Springer US, 2016
ISBN 10: 1489979468ISBN 13: 9781489979469
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Introduces a new, simpler and more effective way in which to interpret pharmaceutical aerosol particle size data from orally inhaled products (OIPs) Outlines a comprehensive product lifecycle management strategy in terms of in vitro characterizati.
Published by Springer US, 2013
ISBN 10: 1461462959ISBN 13: 9781461462958
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Aerodynamic particle size characteristics of orally inhaled products (OIPs) are critical to their performance. Testing based on cascade impaction has been the primary tool used to characterize this critical quality attribute and is a regulatory expectation for Quality Control purposes. In recent years, there have been substantial efforts directed at improving aerodynamic particle size determinations.Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products brings together for the first time a review of best practices for performing cascade impactor testing with a thorough discussion of the newly introduced concepts of abbreviated impactor measurements (AIM) and efficient data analysis (EDA). Topics covered include: Review of pharmacopeial methods (US and European) for aerodynamic particle size distributions (APSD) assessment of OIPs Physical processes that underlie aerosol formation from OIPs and the mechanisms that effect the APSD Good cascade impactor practice (GCIP) related to either full resolution or abbreviated impactor measurements. Introduction of the AIM and EDA concepts Selection of the type of testing through the development lifecycle of an OIP Theoretical basis for EDA Performance evaluation of EDA as a quality control element Case studies related to the application of EDA Experimental studies validating the AIM concept conducted by European Pharmaceutical Aerosol Group (EPAG) and the Cascade Impaction Working Group of the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS). Regulatory and compendial pathways to adoption of AIM and EDA Exploration and extension of AIM as a potential approach to measures more predictive of particle deposition in the human respiratory tract. This comprehensive volume was written by a group of prominent international experts in aerosol testing led by members of the Cascade Impaction Working Group of IPAC-RS. IPAC-RS is an international association of pharmaceutical companies committed to advancing consensus-based, scientifically driven standards and regulations for orally inhaled and nasal drug products.
Published by Springer US, 2016
ISBN 10: 1489979468ISBN 13: 9781489979469
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The purpose of this publication is to introduce a new, simpler and more effective way in which to interpret pharmaceutical aerosol particle size data from orally inhaled products (OIPs). Currently, the compendial and regulatory requirements dictate the need for measurements by full resolution multi-stage cascade impactor (CI), a process that is demanding for the operator, time consuming, prone to experimental error, and challenging for method transfers from one laboratory to another. Furthermore, we shall show that the current practice of reducing information from mass-weighted aerodynamic particle size distribution (APSD) measurements through the use of CI stage groupings is not the most effective decision-making tool for OIP quality control (QC) in comparison with newly introduced, mutually-independent efficient data analysis (EDA) metrics that can be derived either from full resolution or abbreviated impactor measurements (AIM).
Published by Chemical Industry Press, 2022
ISBN 10: 7122393127ISBN 13: 9787122393128
Seller: liu xing, Nanjing JiangSu, JS, China
Book
Hardcover. Condition: New. HardCover.Pub Date:2022-01-01 Pages:398 Language:Chinese Publisher:Chemical Industry Press Methods for in vitro evaluation of mist inhalers (SMIs). dry powder inhalers (DPIs). and inhaler nebulization systems. At the same time. this book introduces the basic theory of cascade impactors for a variety of oral inhalation products. including the concept of simplified impactor measurement (AIM) method and efficient data analysis (EDA) method. and takes the measurement results of marketed products .
Published by Springer, 2013
ISBN 10: 1461462959ISBN 13: 9781461462958
Seller: Mispah books, Redhill, SURRE, United Kingdom
Book
Hardcover. Condition: Like New. Like New. book.